Abiopharma

🔍 Turner Rosemary (Director)

Company: Murphy USA Inc. (MUSA)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Acquired 617 shares of Common Stock (Direct)
  Date: 2026-08-17 | Code: M | equity_swap_involved: 0 | shares_owned_after: 966.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 449 shares of Common Stock (Direct)
  Date: 2026-08-17 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,415.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 617 shares of Restricted Stock Unit (Derivative)
  Date: 2026-08-17 | Code: M | equity_swap_involved: 0 | shares_owned_after: 871.52 | transaction_form_type: 4 | Footnotes: F2, F3, F3, F3, F4
• Sold 449 shares of Restricted Stock Unit (Derivative)
  Date: 2026-08-17 | Code: M | equity_swap_involved: 0 | shares_owned_after: 422.15 | transaction_form_type: 4 | Footnotes: F5, F3, F3, F3, F4

Footnotes:

• F1: Represents Restricted Stock Units ("RSUs") and corresponding dividend equivalents accrued thereon granted to the Reporting Person that have vested and settled in shares of the Company's stock on a one-for-one basis, except for fractional dividend equivalents which have been settled in cash.
• F2: Restricted Stock Unit Award granted under the 2013 Stock Plan for Non-employee Directors.
• F3: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date.
• F4: Includes dividend equivalent units accrued with respect to the underlying RSUs.
• F5: Restricted Stock Unit Award granted under the 2023 Omnibus Incentive Plan.